The Pet Cancer Therapeutics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Pet Cancer Therapeutics Market?
The market size of pet cancer therapeutics has experienced a significant increase in the past few years. It was valued at $0.39 billion in 2024 and is projected to reach $0.43 billion in 2025, growing at a compound annual growth rate (CAGR) of 10.8%. The historical growth trend in the Pet Cancer Therapeutics market has seen a positive upward trajectory.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Pet Cancer Therapeutics Industry?
The pet cancer therapeutics market is projected to expand to $0.65 billion by the year 2029. This growth exhibits a compound annual growth rate (CAGR) of 10.7%.
Download Your Free Sample of the 2025 Pet Cancer Therapeutics Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Pet Cancer Therapeutics Market?
The key drivers in the pet cancer therapeutics market are:
• Expansion of the aging pet population
• Advancements in cancer treatment
• Increase in veterinary oncology services
• Availability of pet insurance and healthcare plans
Global Market Segmentation: Identifying Major Pet Cancer Therapeutics Industry Segments
The pet cancer therapeutics market covered in this report is segmented –
1) By Cancer Type: Melanoma, Mast Cell Cancer, Lymphoma, Mammary And Squamous Cell Cancer
2) By Species: Dogs, Cats, Other Species
3) By Therapy: Chemotherapy, Radiation Therapy, Immunotherapy, TomoTherapy, Other Therapies
4) By End User: Veterinary Hospitals, Clinical Pharmacies, Retail Pharmacies, Online Pharmacies, Other End Users
Pre-order the 2025 Pet Cancer Therapeutics Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Pet Cancer Therapeutics Market?
The key trends in the pet cancer therapeutics market are:
• There is a rising trend in the usage of nutraceuticals and integrative therapies in pet cancer treatments.
• The availability of targeted diagnostic tests for pet cancer is increasing.
• The collaboration between veterinary and human oncology sectors is an emerging trend.
• Introduction of novel chemotherapeutic agents and growing awareness through pet owner education are also shaping the market.
Who Are the Top Competitors & Leading Players in the Pet Cancer Therapeutics Market?
Major companies in the pet cancer therapeutics market are:
• AB Science
• Boehringer Ingelheim GmbH
• Elanco Animal Health
• ELIAS Animal Health
• Zoetis Inc.
• Anivive Lifesciences Inc.
• QBiotics Group Ltd.
• Regeneus Ltd.
• VetDC Inc.
• PetCure Oncology at Veterinary Radiosurgery and Imaging Center
• Torigen Pharmaceuticals Inc.
• Virology and Bacteriology
• Nippon Zenyaku Kogyo Co. Ltd.
• Vivesto AB
• Dechra Pharmaceuticals plc
• Norbrook Laboratories Ltd.
• AdvaVet Inc.
• Oasmia Pharmaceuticals AB
• Zenoaq Co. Ltd.
• Morphogenesis Inc.
• Sumitomo Pharma Animal Health Co.
• Vetivax
• CarthroniX Inc.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the pet cancer therapeutics market in 2024
